HOW IS OLEPTRO DOING??







Quintiles will try to make you believe you will be hired in the future for one of their other projects...it rarely ever happens. Be ready for a song/dance of all the great contracts
they have coming up....it's the same song, different dance.
 
























I do not work for Quintiles --when nothing was posted Friday, I hoped that meant it had not happened.

There is no strategic business sense in announcing lay-offs this close to the end of the quarter. Increasing the amount of bad news and acknowledging ongoing market-share deterioration to those who are not subscribing to industry prescription reports doesn't help in a desperate situation. Besides, lay-offs do next do nothing in solving the core performance issue: a product that no one wants.
 




































There are no "contorted and twisted explanations about what went wrong. Combined with all the coming teleconferences, action plans, activity spreadsheets, etc." Sorry you're not here, the work is hard but the potential is excellent and you probably couldn't handle it.

Sorry the hard work is over. The potential was never there and you probably couldn't handle it.
 






I'm so glad I've been displaced from this contract. Stock is now at .14 cents a share, territories tripled, no raises, my mgr. said he is applying to other jobs and can't wait to get off this contract. It's going nowhere and it's only a matter of time before the contract is over.
 










































How are the things going in the field selling oleptro. The company has said that users and doctors like oleptro? Is this true? Is a problem of price?

Maybe for to say yes is a problem of price. Price to negatively affect doktor and usor liking the Oleptro. Much better the price being helpful, formulary too.